LOX and neoplasm: The significant inhibition of migration and angiogenic properties of pericytes detected upon inhibition of LOX/LOXL activity with the inhibitor βAPN is in agreement with a previous study reporting inhibition of tumor angiogenesis by βAPN treatment in vivo [53].